Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis.

Abstract

BACKGROUND:

Tuberculous meningitis (TBM) is the most lethal form of TB. To study the disease, drug concentrations in samples obtained from the spinal CSF are usually used to reflect brain concentrations. Emerging data suggest that transport of substances across capillaries in the brain (ventricular CSF) and spinal cord may differ.

METHODS:

We examined paired, time-linked samples of ventricular CSF (VCSF) and lumbar CSF (LCSF) of 28 patients with TBM and analysed these for rifampicin and total protein concentrations. Clinically indicated samples from procedures to determine the level of CSF block were collected from children being treated for TBM and hydrocephalus. Total protein concentrations were determined using the bicinchoninic acid (BCA) or turbidimetry assay, and rifampicin concentrations were determined using a validated LC coupled with tandem MS method. A paired Wilcoxon signed-rank test was used to determine significance.

RESULTS:

TBM was confirmed in 19 cases (68%) using TB culture or GeneXpert Mtb/Rifampicin assay. All other cases were classified as probable. The median total protein concentration in LCSF was 6.0 g/L and in VCSF was 1.3 g/L. The median rifampicin concentration in LCSF was 299 ng/mL and 133 ng/mL in VCSF. The median ratio of LCSF/VSCF for protein was 4.23 and 1.57 for rifampicin.

CONCLUSIONS:

Total protein and rifampicin concentrations differed significantly between the two compartments, both being higher in LCSF than in VCSF samples (P < 0.0001 for total protein and P = 0.0046 for rifampicin). Further studies are required to explore the causative reasons for the observed differences.

• Authors: Jill Combrinck, Phophi Tshavhungwe, Ursula Rohlwink, Nico Enslin, Nqobile Thango, Jed Lazarus, Katie Kriegler, Sandra Castel, Noha Abdelgawad, Helen Mcilleron, Paolo Denti, Lubbe Wiesner, Anthony Figaji
• Journal: The Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 79 Issue 2 Pg. 280-286 (Feb 01 2024) ISSN: 1460-2091 [Electronic] England
• PMID: 38101948 (Publication Type: Journal Article)
• Copyright: © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Chemical References

• Rifampin

Topics

• Child
• Humans
• Tuberculosis, Meningeal (drug therapy, cerebrospinal fluid)
• Rifampin (therapeutic use)
• Mycobacterium tuberculosis
• Cerebrospinal Fluid